| Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug? | |
| | |
MedLine Citation:
|
PMID: 20107451 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pregnant women are at particularly high risk for morbidity and mortality from malaria, and pregnancy can markedly affect drug pharmacokinetics, yet the pharmacokinetics of antimalarial drugs in pregnancy has been little studied. An important malaria-control measure in Africa is intermittent preventive therapy (IPT) with sulfadoxine-pyrimethamine (SP) during pregnancy. We discuss IPT with SP in light of several concerns and highlight recent findings from a pharmacokinetic study of SP in this population. |
| | |
Authors:
|
S Parikh; P J Rosenthal |
Publication Detail:
|
Type: Comment; Journal Article |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 87 ISSN: 1532-6535 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-01-28 Completed Date: 2010-02-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 160-2 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA. sparikh@medsfgh.ucsf.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Africa
/
epidemiology Antimalarials / administration & dosage*, adverse effects, pharmacokinetics Clinical Trials as Topic Drug Administration Schedule Drug Combinations Female Humans Malaria, Falciparum / complications, mortality, prevention & control* Plasmodium falciparum / drug effects Pregnancy Pregnancy Complications, Parasitic / prevention & control Pyrimethamine / administration & dosage*, adverse effects, pharmacokinetics Sulfadoxine / administration & dosage*, adverse effects, pharmacokinetics |
| Chemical | |
Reg. No./Substance:
|
0/Antimalarials; 0/Drug Combinations; 2447-57-6/Sulfadoxine; 37338-39-9/sulfadoxine-pyrimethamine; 58-14-0/Pyrimethamine |
| Comments/Corrections | |
Comment On:
|
Clin Pharmacol Ther. 2010 Feb;87(2):226-34
[PMID:
19776738
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessing the safety and comparative effectiveness of follow-on biologics (biosimilars) in the Unite...
Next Document: BOUNCE: A Community-based Mother-daughter Healthy Lifestyle Intervention for Low-income Latino Famil...